STIM News and Press, Neuronetics Inc.

MALVERN, Pa., June 13, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced today their participation at the 1...

MALVERN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that the management team will...

MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders announced today that Humana has become the fir...

2024-05-09 02:35:55 ET Summary Neuronetics' share price dropped after reporting soft Q1 2024 results, with weak system sales undermining strong treatment demand. Neuronetics' losses remain relatively large, and the company's balance sheet provides it with limited flexibility. ...

2024-05-07 17:16:09 ET Neuronetics, Inc. (STIM) Q1 2024 Results Conference Call May 07, 2024 08:30 AM ET Company Participants Mark Klausner - Investor Relations Keith Sullivan - President, Chief Executive Officer Steve Furlong - Chief Financial Officer Conf...

A look at the top 10 most actives in the United States Pineapple Energy Inc. (PEGY) rose 42.3% to $0.0757 on volume of 309,082,980 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 5.8% to $0.0437 on volume of 170,654,366 shares Palantir Technologies Inc. Class A (PLTR) fell 15....

2024-05-07 12:46:58 ET More on Mid-day movers & stocks. Pineapple Energy Inc. (PEGY) Q4 2023 Earnings Call Transcript Financial information for Integrated Media Technology Financial information for Mmtec Seeking Alpha’s Quant Rating on Pineapple En...

2024-05-07 07:33:44 ET More on Neuronetics Neuronetics, Inc. (STIM) Q4 2023 Earnings Call Transcript Neuronetics gets FDA nod for NeuroStar as add-on treatment for adolescents with depression Neuronetics announces 5-year exclusive partnership with TCN Seeking...

MALVERN, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with ...

Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...